Currently, there are 1.63B common shares owned by the public and among those 1.24B shares have been available to trade.
The company’s stock has a 5-day price change of 4.64% and 22.13% over the past three months. MS shares are trading 12.88% year to date (YTD), with the 12-month market performance up to 22.10% higher. It has a 12-month low price of $69.42 and touched a high of $105.82 over the same period. MS has an average intraday trading volume of 6.04 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.45%, 7.41%, and 19.27% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Morgan Stanley (NYSE: MS) shares accounts for 61.28% of the company’s 1.63B shares outstanding.
It has a market capitalization of $171.06B and a beta (3y monthly) value of 1.37. The stock’s trailing 12-month PE ratio is 19.18, while the earnings-per-share (ttm) stands at $5.49. The company has a PEG of 2.40 and the debt-to-equity ratio at 3.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.12% over the week and 1.60% over the month.
Earnings per share for the fiscal year are expected to increase by 32.01%, and 10.42% over the next financial year. EPS should grow at an annualized rate of 8.00% over the next five years, compared to 1.84% over the past 5-year period.
Looking at the support for the MS, a number of firms have released research notes about the stock. Keefe Bruyette stated their Mkt Perform rating for the stock in a research note on January 17, 2024, with the firm’s price target at $102-$91. JP Morgan coverage for the Morgan Stanley (MS) stock in a research note released on January 17, 2024 offered a Neutral rating with a price target of $87. Exane BNP Paribas on their part issued Neutral rating on November 20, 2023.
